New horizons in hypoxia signalling
In plain English
AI plain-English summaryEvery living cell needs oxygen to function, and when oxygen levels drop—during a heart attack, stroke, or even a high-altitude climb—the body must respond in seconds, not minutes. Scientists already know one major oxygen-sensing system, called HIF/PHD, but it works by switching genes on and off, which is too slow to explain the body’s instant reflexes to low oxygen. This project investigates a newly discovered, faster oxygen-sensing system in human cells. It centres on an enzyme called ADO, which directly modifies signalling proteins and marks them for destruction when oxygen is present—a process that can happen far more quickly than gene-based responses. The researchers will identify which proteins ADO targets, how this system interacts with the slower HIF/PHD pathway, and whether it helps excitable cells like neurons fire rapid electrical signals in response to oxygen changes. If successful, this work will rewrite the textbook understanding of how the body maintains oxygen balance. It is fundamental science, not a therapy in development. But past discoveries in oxygen sensing have already led to drugs for anaemia and cancer. A deeper grasp of this second, faster system could eventually open new routes for treating conditions where oxygen supply is suddenly compromised—stroke, heart attack, or respiratory failure.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Discovery AwardPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know